Compare ADMA Biologics Inc (ADMA) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs United States Natural Gas Fund — how do they compare? ADMA Biologics Inc trades at $9.23 (market cap $2.13B), while United States Natural Gas Fund trades at $11.61. Which is the better fit depends on your goals.
| ADMA | UNG | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | Commodities - Energy |
52-Week High | $20.38 | $16.90 |
52-Week Low | $7.60 | $10.15 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
UNG trades at $11.71, up 1.12% today, with a bullish technical signal driven by moving averages. The fund tracks natural gas futures, with sentiment influenced by weather-driven demand and LNG export flows. Recent news highlights volatility from storage data and production forecasts, while technical indicators like RSI remain neutral.
Outlook hinges on natural gas price trends, with upside from demand spikes but risks from contango and ample supply. Investors face structural challenges, as noted in analysis citing decade-long losses, requiring caution despite short-term bullish signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
